Danfeng Dong

Danfeng Dong

Auto-generated profile, based on publicly available information

Danfeng Dong

Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 August 2016 in Mycopathologia
Verified
Journal Article
Closed access
PDF file
CJCen Jiang
Cen Jiang
QNQi Ni
Qi Ni
DDDanfeng Dong
Danfeng Dong
LZLihua Zhang
Lihua Zhang
ZLZhen Li
Zhen Li
YPYibing Peng
Yibing Peng

10 August 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
YLYide Lu
Yide Lu
FYFan Yang
Fan Yang
DWDongmei Wen
Dongmei Wen
KSKaifeng Shi
Kaifeng Shi
ZGZhichao Gu
Zhichao Gu
DDDanfeng Dong
Danfeng Dong
Background: It is critical for laboratories to conduct multianalyzer comparisons as a part of daily routine work to strengthen the quality management of test systems. Here, we explored the application of patient‐based real‐time quality controls (PBRTQCs) on comparative assays to monitor the consistency among clinical laboratories.Methods: The present study included 11 commonly tested analytes that were detected using three analyzers. PBRTQC procedures were set up with exponentially weighted moving average (EWMA) algorithms and evaluated using the AI‐MA artificial intelligence platform. Comparative assays were carried out on serum samples, and patient data were collected. Patients were divided into total patient (TP), inpatient (IP), and outpatient (OP) groups.Results: Optimal PBRTQC protocols were evaluated and selected with appropriate truncation limits and smoothing factors. Generally, similar comparative assay performance was achieved using both the EWMA and median methods. Good consistency between the results from patients' data and serum samples was obtained, and unacceptable bias was detected for alkaline phosphatase (ALP) and gamma‐glutamyl transferase (GGT) when using analyzer C. Categorizing patients' data and applying specific groups for comparative assays could significantly improve the performance of PBRTQCs. When monitoring the inter‐ and intraanalyzer stability on a daily basis, EWMA was superior in detecting very small quality‐related changes with lower false‐positive alarms.Conclusions: We found that PBRTQCs have the potential to efficiently assess multianalyzer comparability. Laboratories should be aware of population variations concerning both analytes and analyzers to build more suitable PBRTQC protocols.

21 December 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
TSTongxuan Su
Tongxuan Su
WCWei Chen
Wei Chen
DWDaosheng Wang
Daosheng Wang
YCYingchao Cui
Yingchao Cui
QNQi Ni
Qi Ni
YPYibing Peng
Yibing Peng
Toxin A-negative, toxin B-positiveClostridioides difficilestrains, which primarily include the ST81 and ST37 genotypes, are predominant inC. difficileinfections leading to antibiotic-associated diarrhea in China. Recently, ST81 has been reported as the most prevalent genotype rather than ST37, although the genetic and functional characteristics of the two genotypes remain ambiguous. In this study, we conducted comprehensive comparative analysis of these two genotypes through complete genome sequencing and phenotypic profiling. The whole genome sequencing revealed that the ST81 and ST37 isolates were closely related genetically with similar gene compositions, and high rate of the core genome shared. The integrative and conjugative elements identified in ST81 were similar to those in ST37, albeit with more diverse and insertion regions. By characterizing the phenotypes related to colonization or survival in the host, we found that the ST81 isolates exhibited robust colonization ability and survival bothin vitroandin vivo, enhanced spore production, and slightly increased motility, which may be attributable to the discrepancy in non-synonymous single-nucleotide polymorphisms in the relevant functional genes. Furthermore, the ST81 isolates displayed a significantly higher rate of resistance to fluoroquinolones compared with the ST37 isolates (94.12% vs. 62.5%) and mostly carried the amino acid substitution Asp426Val in GyrB. In summary, the results of our study indicate that ST81 isolates exhibit enhanced ability to transmit between hosts and survive in harsh environments, providing key genetic insights for further epidemiological investigations and surveillance ofC. difficileinfection.

21 January 2025 in JCI Insight
Verified
Journal Article
Open access
PDF file
DWDaosheng Wang
Daosheng Wang
SSSilei Sun
Silei Sun
QZQianli Zhao
Qianli Zhao
BZBing Zhao
Bing Zhao
LMLi Ma
Li Ma
EMEnqiang Mao
Enqiang Mao
Infectious complications (ICs) in acute pancreatitis (AP) are primarily driven by intestinal bacterial translocation, significantly increasing mortality and hospital stays. Despite this, the role of the gut microenvironment, particularly its metabolic aspects, in AP remains poorly understood. In this study, we investigated a cohort of patients with AP, and conducted supplemental murine studies, to explore the relationship between the gut metabolome and the development of ICs. Metabolomic analysis revealed that disruptions in gut tryptophan metabolism — especially reductions in serotonin and indole pathways — are key features associated with IC occurrence. Additionally, elevated plasma levels of tryptophan metabolites within the kynurenine pathway were identified as valuable predictive biomarkers for ICs. Mechanistic studies in murine models demonstrated that an impaired intestinal Th17 response, modulated by these tryptophan metabolites, plays a critical role in IC development. Serotonin supplementation enhanced Th17 responses, reducing IC incidence, while administration of kynurenic acid, a kynurenine metabolite, exacerbated pancreatic infections, potentially through immunosuppressive effects. These findings highlight the pivotal role of tryptophan metabolites in AP pathogenesis, emphasizing their potential as both predictive markers and therapeutic targets in IC management.

29 March 2026 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
FFFangfang Fan
Fangfang Fan
YZYu Zeng
Yu Zeng
QZQianli Zhao
Qianli Zhao
TSTongxuan Su
Tongxuan Su
YSYining Shen
Yining Shen
YPYibing Peng
Yibing Peng
Clostridioides difficile (CD) is a leading cause of antibiotic‐associated diarrhoea in both hospitalized and non‐hospitalized patients. This study explores the role of extracellular vesicles (EVs) derived from Clostridioides difficile strain 630 (CD630‐EVs), which released spherical EVs during in vitro culture, in modulating pro‐inflammatory cytokine production in macrophages. Proteomic analysis identified a total of 1064 proteins within CD630‐EVs, including four immune‐related proteins: FliC, TrxA, TrxA2 and HtpG. Notably, FliC exhibited the highest expression intensity within immune‐related pathways. CD630‐EVs significantly stimulated the production of inflammatory factors, such as interleukin (IL)‐6, monocyte chemoattractant protein‐1 (MCP‐1), IL‐1α and TNF‐α, in mouse macrophages. However, the addition of TH1020, a flagellin receptor inhibitor, markedly suppressed cytokine production. Protein docking analysis further demonstrated that TH1020 disrupts the interaction between Toll‐Like Receptor 5 (TLR5) and FliC, thereby attenuating FliC‐mediated inflammatory responses in macrophages. FliC likely plays a pivotal role in mediating the inflammatory response induced by CD630‐EVs in macrophages. This effect is potentially driven by the activation of innate immunity through FliC's interaction with TLR5 in the host, which may subsequently influence adaptive immune responses. In conclusion, this study elucidates the immune‐modulatory effects of CD630‐EVs on host macrophages during Clostridioides difficile infection (CDI). CD630‐EVs contain a diverse array of proteins, with FliC emerging as a key mediator of pro‐inflammatory responses in macrophages. These findings suggest that FliC may play a critical role in intestinal mucosal injury during CDI, highlighting its potential as a therapeutic target for mitigating inflammation in CDI.

1 February 2021 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
WTWen‐Jie Tian
Wen‐Jie Tian
QWQian‐Nan Wang
Qian‐Nan Wang
XWXue‐Feng Wang
Xue‐Feng Wang
DDDan‐Feng Dong
Dan‐Feng Dong